Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Subbarao

Showing results (291-300 of 310) with videos related to

Pageof 31
Sort By:
JMIR Public Health and Surveillance|June 17, 2024
Malaria Vector Bionomics: Countrywide Surveillance Study on Implications for Malaria Elimination in IndiaManju Rahi, A K Mishra, Gyan Chand, et al.
Scientific Reports|April 24, 2025
Detection of a sympatric cryptic species mimicking Aedes albopictus (Diptera: Culicidae) in dengue and Chikungunya endemic forest villages of Tripura, India, posing a daunting challenge for vector researchSaurav Biswas, Jadab Rajkonwar, Sasmita Rani Jena, et al.
Arthritis and Rheumatism|July 28, 2010
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritisLeo A B Joosten, Mihai G Netea, Eleni Mylona, et al.
Nature|December 3, 2020
Galactosaminogalactan activates the inflammasome to provide host protectionBenoit Briard, Thierry Fontaine, Parimal Samir, et al.
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in IndiaP G Vathsala, A Pramanik, S Dhanasekaran, et al.
Nature|December 22, 2020
Publisher Correction: Galactosaminogalactan activates the inflammasome to provide host protectionBenoit Briard, Thierry Fontaine, Parimal Samir, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
Cell|November 29, 2025
Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosisYaqiu Wang, Jianlin Lu, Alexandre F Carisey, et al.
Cell|June 23, 2015
Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and CancerSi Ming Man, Qifan Zhu, Liqin Zhu, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 31

Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
JMIR Public Health and Surveillance|June 17, 2024
Malaria Vector Bionomics: Countrywide Surveillance Study on Implications for Malaria Elimination in IndiaManju Rahi, A K Mishra, Gyan Chand, et al.
Scientific Reports|April 24, 2025
Detection of a sympatric cryptic species mimicking Aedes albopictus (Diptera: Culicidae) in dengue and Chikungunya endemic forest villages of Tripura, India, posing a daunting challenge for vector researchSaurav Biswas, Jadab Rajkonwar, Sasmita Rani Jena, et al.
Arthritis and Rheumatism|July 28, 2010
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritisLeo A B Joosten, Mihai G Netea, Eleni Mylona, et al.
Nature|December 3, 2020
Galactosaminogalactan activates the inflammasome to provide host protectionBenoit Briard, Thierry Fontaine, Parimal Samir, et al.
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in IndiaP G Vathsala, A Pramanik, S Dhanasekaran, et al.
Nature|December 22, 2020
Publisher Correction: Galactosaminogalactan activates the inflammasome to provide host protectionBenoit Briard, Thierry Fontaine, Parimal Samir, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
Cell|November 29, 2025
Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosisYaqiu Wang, Jianlin Lu, Alexandre F Carisey, et al.
Cell|June 23, 2015
Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and CancerSi Ming Man, Qifan Zhu, Liqin Zhu, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 31